Power-controlled waveform in electrosurgical systems

US12440262B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12440262-B2
Application numberUS-202318338594-A
CountryUS
Kind codeB2
Filing dateJun 21, 2023
Priority dateMay 9, 2019
Publication dateOct 14, 2025
Grant dateOct 14, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.

First claim

Opening claim text (preview).

The invention claimed is: 1. A surgical generator configured to generate and provide controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the surgical generator comprising: a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to: control the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by increasing the electrical power as a function of resistance, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase. 2. The surgical generator of claim 1 , wherein the control circuit is configured to: control a voltage of the therapeutic signal provided to the biological tissue during a portion of a drying phase according to the therapeutic plan. 3. The surgical generator of claim 2 , wherein the control circuit is configured to: monitor the voltage of the therapeutic signal; and maintain the voltage when the voltage meets a voltage threshold. 4. The surgical generator of claim 1 , wherein the control circuit is configured to: control the electrical power of the therapeutic signal provided to the biological tissue during the portion of the therapeutic phase using a pre-defined power curve. 5. The surgical generator of claim 4 , wherein the pre-defined power curve includes a linear portion. 6. The surgical generator of claim 4 , wherein the pre-defined power curve includes two or more linear portions. 7. A method of delivering controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the method comprising: generating, using an electrical-energy source electrically coupled to the instrument, the therapeutic signal; and controlling the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by increasing the electrical power as a function of resistance or current, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase. 8. The method of claim 7 , comprising: controlling a voltage of the therapeutic signal provided to the biological tissue during a portion of a drying phase according to the therapeutic plan. 9. The method of claim 8 , comprising: monitoring the voltage of the therapeutic signal; and maintaining the voltage when the voltage meets a voltage threshold. 10. The method of claim 7 , comprising: controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the therapeutic phase using a pre-defined power curve. 11. The method of claim 10 , wherein the pre-defined power curve includes a linear portion. 12. The method of claim 11 , wherein the pre-defined power curve includes two or more linear portions. 13. The method of claim 11 , wherein controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the non-sealing therapeutic phase according to the therapeutic plan by increasing the electrical power as a function of resistance or current includes: controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the non-sealing therapeutic phase according to the therapeutic plan by increasing the electrical power as a function of current. 14. The method of claim 13 , wherein the function of current is a function of an instantaneous measured change in current. 15. The method of claim 14 , wherein the function of the instantaneous measured change in current is a linear function. 16. The method of claim 11 , wherein controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the non-sealing therapeutic phase according to the therapeutic plan by increasing the electrical power as a function of resistance or current includes: controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the non-sealing therapeutic phase according to the therapeutic plan by increasing the electrical power as a function of resistance. 17. A surgical generator configured to generate and provide controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the surgical generator comprising: a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to: control the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by increasing the electrical power as a function of current, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase. 18. The surgical generator of claim 17 , wherein the function of current is a function of an instantaneous measured change in current. 19. The surgical generator of claim 17 , comprising: controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the therapeutic phase using a pre-defined power curve. 20. The surgical generator of claim 19 , wherein the pre-defined power curve includes a linear portion.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12440262B2 cover?
Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The el…
Who is the assignee on this patent?
Gyrus Acmi Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/1206. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).